We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site. To find out more, including how to change your settings, see our Cookie Policy.
Accept

Popular Blood Pressure Medication Recalled For Cancer- Risk Causing EXPANDING- High Recall Alert Happening

latest
August 21, 2018

On Monday, August 20th, the Food and Drug Administration announced the recall of the popular blood pressure medication containing valsartan was expanding.

https://twitter.com/UNDAuthority/status/1030340436458721280

The original recall for medication containing valsartan was live on July 13th, 2018. The recall was discovered after the active ingredient, valsartan, was found to have an impurity: N-nitrosodimethylamine (NDMA).

https://twitter.com/CTVToronto/status/1031596646717685762

According to the FDA, “NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests.” NDMA has been known to cause cancer.

https://twitter.com/globalnews/status/1031564853184487424

However, the FDA also states that “Not all valsartan products contain NDMA, so pharmacists may be able to provide a refill of valsartan medication not affected by the recall, or doctors may prescribe a different medication that treats the same condition." To get a full list of the affected medications, click here.

https://twitter.com/USRecallNews/status/1031690830866731008

If you are not sure if your medication is affected by this recall, The FDA advises consumers to call 1-800-505-9291 or email recall@qualanex.com with any questions or concerns.

https://twitter.com/SGottliebFDA/status/1031624241404366849

While the number of drugs affected is growing every day, it is important to reach out to your doctor if you are currently using any medication with this valsartan. Please consult your doctor.

Share this story on Facebook to raise awareness!